There is every indication that innovations in pharmacotherapy will continue to play a crucial role in the clinical management of patients with glaucoma. During this webcast event, experts will discuss the current state of medical management of glaucoma and the various pipeline entities that proffer to increase the odds of helping patients with glaucoma preserve their vision. We will discuss new classes of medications, intriguing research on drug delivery devices, and exciting theories about how we approach treatment that may unveil potential curative strategies
This course features bonus case material. View it here
This continuing medical education activity is supported through an educational grant from Bausch & Lomb Incorporated.
Upon completion of this activity, the participant should be able to:
Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians
Credit Designation Statement
Evolve Medical Education LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Jason Bacharach, MD
North Bay Eye Associates
Murray Fingeret, OD
New York Harbor Healthcare System
Brooklyn, New York
EDITORIAL SUPPORT DISCLOSURES
Cheryl Cavanaugh, MS, director of operations, Evolve Medical Education LLC, and Michelle Dalton, medical writer, have no real or apparent conflicts of interest to report.
Rishi P. Singh, MD, peer reviewer, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/ Speaker’s Bureau: Alcon; Allergan; Carl Zeiss Meditec; Genentech; Optos; Regeneron Pharmaceuticals; and Shire Plc. Grant/Research Support: Alcon; Apellis Pharmaceuticals; Genentech; and Regeneron Pharmaceuticals.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education LLC and Bausch & Lomb Incorporated